OrganOx

📍 Oxford, United Kingdom🗓 Founded 2008👥 209 employees💰 Last funded 2025
Transforming transplantation with the OrganOx metra®. A transportable, automated ex vivo liver perfusion device. The core technology employed by the OrganOx metra® has been in development for over 15 years. During this time both of the founders (Professor Peter Friend and Professor Constantin Coussios) have driven the development of organ preservation and maintenance, formerly at the University of Cambridge and latterly at the University of Oxford. OrganOx Limited was founded in April 2008 as a spin-out from the University of Oxford. Conventional cold preservation involves storage of the liver at 4˚C, using a non-physiological perfusion solution that aims to minimise liver decay. By contrast, warm preservation seeks to re-create an environment that mimics the human body by continuously perfusing at physiological pressures and flows with oxygen-carrying red cells at 37˚C and providing nutrition. The liver is therefore functional during the preservation period, producing bile, metabolizing glucose and maintaining a physiological pH. This enables objective assessment of organ performance prior to transplant, extended preservation times, and the potential use of organs that are presently being discarded.
4
Total investors
0
Early stage
0
Mid stage
1
Late stage
2008
Founded
Investor geography2 countries
United Kingdom
3
United States
1
Investor activity2014–2025 · investors recorded per year
20141201912021120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in OrganOx?
OrganOx has 4 investors on record on gritt.io and 1 late-stage investors.
When did OrganOx last raise funding?
The most recent investment in OrganOx recorded on gritt.io was in 2025.
When was OrganOx founded?
OrganOx was founded in 2008.
What industry is OrganOx in?
OrganOx operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is OrganOx based?
OrganOx is headquartered in Oxford, United Kingdom.